Ensaka C

No ORCID on file · 1 paper in corpus · active 2022
2022
A novel orally active gonadotropin-releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology.
Reproductive medicine and biology ·doi:10.1002/rmb2.12424

PurposeTo evaluate the efficacy of an oral gonadotropin-releasing hormone antagonist (GnRH Ant), relugolix (R), for assisted reproductive technology (ART).MethodsWe enrolled women undergoing ART using a GnRH Ant for controlled ovarian stimu…